Board of Directors
William C. Weldon
Chairman, Board of Directors; Chief Executive Officer; and Chairman, Executive Committee
Mary Sue Coleman, Ph.D.
President, University of Michigan
James G. Cullen
Retired President and Chief Operating Officer, Bell Atlantic Corporation
Ian E. L. Davis
Managing Director Emeritus; Former Worldwide Managing Director, McKinsey & Company
Michael M.E. Johns, M.D.
Chancellor, Emory University
Susan L. Lindquist, Ph.D.
Member and Former Director, Whitehead Institute for Biomedical Research; Professor of Biology, Massachusetts Institute of Technology
Anne M. Mulcahy
Former Chairman and Chief Executive Officer, Xerox Corporation
Leo F. Mullin
Retired Chairman and Chief Executive Officer, Delta Air Lines, Inc.
William D. Perez
Senior Advisor, Greenhill & Co., Inc.; Retired President and Chief Executive Officer, Wm. Wrigley Jr. Company
Charles Prince
Chairman, Sconset Group, LLC; Senior Counselor, Albright Capital Management LLC; Retired Chairman and Chief Executive Officer, Citigroup Inc.
David Satcher, M.D., Ph.D.
Director, Center of Excellence on Health Disparities, Director, Satcher Health Leadership Institute and Poussaint-Satcher-Cosby Chair in Mental Health, Morehouse School of Medicine; Former U.S. Surgeon General
Committees of the Board
Audit
The Audit Committee, composed entirely of independent Directors, helps the Board oversee the Company’s financial accounting and reporting practices. It recommends the independent public auditor for appointment by the Board and reviews its performance. In addition, the Committee monitors the adequacy of internal accounting practices; procedures and controls; reviews the Company’s financial reporting process and disclosure procedures; and helps the Board oversee the Company’s legal compliance programs.
James G. Cullen, Chairman
Mary Sue Coleman, Ph.D.
Ian E. L. Davis
Leo F. Mullin
Compensation & Benefits
The Compensation & Benefits Committee, composed entirely of independent Directors, establishes the Company’s executive compensation philosophy and principles and approves the annual compensation and long-term incentives for the Company’s directors and executive officers. The Committee also reviews the philosophy and policies of the non-Board Management Compensation Committee, which determines management compensation and establishes perquisites and other compensation policies for non-executive employees. Additionally, the Committee oversees the management of the various retirement, pension, long-term incentive, savings, health and welfare plans that cover the Company’s employees.
Charles Prince, Chairman
Michael M. E. Johns, M.D.
Anne M. Mulcahy
William D. Perez
Finance
The Finance Committee exercises the authority of the Board during the intervals between Board meetings. The Finance Committee is composed of the Chairman of the Board and the Presiding Director.
William C. Weldon, Chairman
James G. Cullen
Nominating & Corporate Governance
The Nominating & Corporate Governance Committee, composed entirely of independent Directors, is responsible for overseeing corporate governance matters, reviewing possible candidates for Board membership and recommending nominees for election. The Committee is also responsible for overseeing the process for performance evaluations of the Board and its committees. Additionally, the Committee reviews the Company’s executive succession plans and executive resources.
William D. Perez, Chairman
James G. Cullen
Anne M. Mulcahy
Charles Prince
Public Policy
The Public Policy Advisory Committee reviews the Company’s policies, programs and practices on public health issues regarding the environment and the health and safety of employees. The Committee also reviews the Company’s governmental affairs and policies and other public policy issues facing the Company. The Committee advises and makes recommendations to the Board on these issues as appropriate. The Public Policy Advisory Committee is composed of independent Directors; one of the Company's Vice Chairmen, Executive Committee; and the Vice Presidents for Corporate Affairs, Government Affairs and Policy, and Johnson & Johnson Supply Chain.
Leo F. Mullin, Chairman
Ian E. L. Davis
Alex Gorsky
Clifford E. Holland
Susan L. Lindquist, Ph.D.
Brian D. Perkins
David Satcher, M.D., Ph.D
Ajit S. Shetty, Ph.D.
Science & Technology
The Science & Technology Advisory Committee, composed of independent Directors and the Company’s Vice President, Science and Technology, helps the Board with scientific matters impacting the Company’s business, including monitoring the strategy and effectiveness of the Company’s research and development organization; reviewing the effectiveness of scientific aspects of the Company’s product safety processes; overseeing major business development activities related to the acquisition of new science or technology; and identifying and understanding significant new science and technology policy issues and trends.
David Satcher, M.D., Ph.D., Chairman
Mary Sue Coleman, Ph.D.
Michael M. E. Johns, M.D.
Susan L. Lindquist, Ph.D.
Garry A. Neil, M.D.
Corporate Officers
Executive Committee
William C. Weldon
Chairman, Board of Directors
Chief Executive Officer
Chairman, Executive Committee
Dominic J. Caruso
Vice President, Finance
Chief Financial Officer
Executive Committee
Douglas K. Chia
Corporate Secretary
Assistant General Counsel
Stephen J. Cosgrove
Corporate Controller
Laverne H. Council
Vice President
Chief Information Officer
Russell C. Deyo
Vice President
General Counsel
Executive Committee
Peter M. Fasolo
Worldwide Vice President
Human Resources
Executive Committee
ALEX GORSKY
Vice Chairman
Executive Committee
Raymond C. Jordan
Vice President
Public Affairs &
Corporate Communication
Sherilyn S. McCoy
Vice Chairman
Executive Committee
John A. Papa
Treasurer
Brian D. Perkins
Vice President
Corporate Affairs
The Executive Committee of Johnson & Johnson is the principal management group responsible for the operations and allocation of the resources of the Company. This Committee oversees and coordinates the activities of the Consumer, Pharmaceuticals and Medical Devices and Diagnostics business segments. Each subsidiary within the business segments is, with some exceptions, managed by citizens of the country where it is located.
Worldwide Chairmen
CONSUMER GROUP
Jesse J. Wu
MEDICAL DEVICES & DIAGNOSTICS GROUP
Michael F. Mahoney
PHARMACEUTICALS GROUP
Joaquin Duato
Paul Stoffels, M. D.